Potent and Specific Inhibition of NTCP-Mediated HBV/HDV Infection and Substrate Transporting by a Novel, Oral-Available Cyclosporine A Analogue

Potent and Specific Inhibition of NTCP-Mediated HBV/HDV Infection and Substrate Transporting by a Novel, Oral-Available Cyclosporine A Analogue Synthesis and biological evaluation of [d-lysine]8cyclosporin A analogs as potential anti-HCV agents In vitro anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA ReplicationIn Vitro Entry inhibition of hepatitis B virus using cyclosporin O derivatives with peptoid side chain incorporation Cyclophilin inhibitors as antiviral agents Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection Synthesis and Biological Evaluation of Novel Cyclosporin A Analogues:  Potential Soft Drugs for the Treatment of Autoimmune Diseases Synthesis of non-immunosuppressive cyclophilin-Binding cyclosporin A derivatives as potential anti-HIV-1 drugs Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections